These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 617072)

  • 41. Comparison of four different dosages of injectable bromocriptine retard for puerperal ablactation.
    Duthie SJ; Fuk-Him DL; Fang AH; O'Hoy KM; Pak-Chung H
    Eur J Obstet Gynecol Reprod Biol; 1990 Mar; 34(3):223-8. PubMed ID: 2311809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of puerperal lactation with 2-mercaptopropionyl-glycine.
    Akrivis C; Vezyraki P; Kiortsis DN; Fotopoulos A; Evangelou A
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):621-3. PubMed ID: 11214766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
    Varga L; Lutterbeck PM; Pryor JS; Wenner R; Erb H
    Br Med J; 1972 Jun; 2(5816):743-4. PubMed ID: 4556543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of bromocriptine on lactation and plasma progesterone in Bettongia gaimardi, a Tasmanian macropodid marsupial.
    Rose RW; Jones SM; Macfadyen AS
    Reprod Fertil Dev; 1996; 8(7):1061-7. PubMed ID: 8916282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation: a controlled study.
    Biggs JS; Hacker N; Andrews E; Munro C
    Med J Aust; 1978 Nov; 2(3 Suppl):23-5. PubMed ID: 370526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum prolactin levels during inhibition of lactation with 2-brom-alpha-ergocryptin (CB 154) (author's transl)].
    Gerstner G; Mick R; Spona J
    Wien Klin Wochenschr; 1977 Oct; 89(19):664-7. PubMed ID: 910447
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
    Wolf R
    Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The lactation-blocking drug bromocriptine and its application to studies of weaning and behavioral development.
    Martin P; Bateson P
    Dev Psychobiol; 1982 Mar; 15(2):139-57. PubMed ID: 7095282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of puerperal lactation using 2 brom-ergocryptine.
    Walker S
    Br J Obstet Gynaecol; 1975 Oct; 82(10):845. PubMed ID: 1103961
    [No Abstract]   [Full Text] [Related]  

  • 54. Lack of action of prolactin suppression on the regulation of the human menstrual cycle.
    del Pozo E; Goldstein M; Friesen H; Brun del Re R; Eppenberger U
    Am J Obstet Gynecol; 1975 Dec; 123(7):719-23. PubMed ID: 1239194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lactation suppression and puerperal fever.
    Almeida OD; Kitay DZ
    Am J Obstet Gynecol; 1986 Apr; 154(4):940-1. PubMed ID: 3963089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of lactation.
    Llewellyn-Jones D
    Drugs; 1975; 10(2):121-9. PubMed ID: 1175477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of lactation in rabbits by 2-Br-alpha-Ergokryptine-mesilate (CB154).
    Flückiger E; Billeter E; Wagner HR
    Arzneimittelforschung; 1976; 26(1):51-3. PubMed ID: 947176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bromocriptine and alpha-ergocryptine do not inhibit oxytocin secretion in the lactating rat.
    Russell JA; Harrison DJ; McNeilly AS
    J Endocrinol; 1981 Apr; 89(1):91-8. PubMed ID: 6894307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
    Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin response to TRH during inhibition of puerperal lactation with ergolinic drugs.
    Crosignani PG; Lombroso GC; Trojsi L; Caccamo A; Reschini E; Peracchi M
    Horm Metab Res; 1977 Mar; 9(2):163-4. PubMed ID: 405303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.